Skip to main content Back to Top
Advertisement

11/22/2022

Etomidate Injection

Products Affected - Description

    • Amidate injection, Pfizer, 2 mg/mL, 10 mL vial, 10 count, NDC 00409-6695-01
    • Amidate injection, Pfizer, 2 mg/mL, 20 mL vial, 10 count, NDC 00409-6695-02
    • Etomidate injection, Eugia US, 2 mg/mL, 10 mL vial, 10 count, NDC 55150-0221-10
    • Etomidate injection, Eugia US, 2 mg/mL, 20 mL vial, 10 count, NDC 55150-0222-20
    • Etomidate injection, Fresenius Kabi, 2 mg/mL, 10 mL vial, 10 count, NDC 65219-0445-10
    • Etomidate injection, Fresenius Kabi, 2 mg/mL, 20 mL vial, 10 count, NDC 65219-0447-10
    • Etomidate injection, Hikma, 2 mg/mL, 10 mL vial, 10 count, NDC 00143-9506-10
    • Etomidate injection, Hikma, 2 mg/mL, 20 mL vial, 10 count, NDC 00143-9507-10
    • Etomidate injection, Mylan Institutional (Viatris), 2 mg/mL, 10 mL vial, 10 count, NDC 67457-0902-10
    • Etomidate injection, Mylan Institutional (Viatris), 2 mg/mL, 20 mL vial, 10 count, NDC 67457-0903-20

Reason for the Shortage

    • Pfizer has etomidate on shortage due to manufacturing delays.
    • Eugia has etomidate on shortage due to increased demand.
    • Hikma did not provide a reason for the shortage.
    • Viatris (Mylan Institutional) did not provide a reason for the shortage.

Available Products

    • Etomidate injection, Sagent, 2 mg/mL, 10 mL vial, 10 count, NDC 25021-0674-10
    • Etomidate injection, Sagent, 2 mg/mL, 20 mL vial, 10 count, NDC 25021-0674-20

Estimated Resupply Dates

    • Eugia has etomidate 2 mg/mL 10 mL and 20 mL vials on back order and the company estimates a release date of late-December 2022.
    • Fresenius Kabi has short-dated etomidate 2 mg/mL 10 mL and 20 mL vials available with an expiration date of < 3 months.
    • Hikma has etomidate 2 mg/mL 10 mL and 20 mL vials on back order and the company estimates a release date of late-November to early-December 2022 for the 10 mL vials and late-January to early-February 2023 for the 20 mL vials.
    • Viatris has etomidate 2 mg/mL 10 mL and 20 mL vials on back order and the company estimates a release date of late-March 2023.
    • Pfizer has Amidate 2 mg/mL 10 mL and 20 mL vials on back order and the company estimates a release date of March 2023 for the 10 mL vials and February 2023 for the 20 mL vials.

Updated

Updated November 22, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 5, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.